Veracyte (NASDAQ: VCYT) reported Q1 EPS of $0.52, $0.19 better than the analyst estimate of $0.33. Revenue for the quarter came in at $139.07 million versus the consensus estimate of $130.15 million.

GUIDANCE:

Veracyte sees FY2026 revenue of $582-592 million, versus the consensus of $576.4 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.